Thursday, February 2, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

Foot-and-Mouth Disease Vaccine Field Trials

by Global Biodefense Staff
March 2, 2015
Biodefense Vaccine Program

The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T), Chemical and Biological Division (CBD), Agricultural Defense Branch is conducting market research to identify organizations capable of advancing Foot-and-Mouth Disease countermeasures.

Required activities will support advanced development of human adenovirus-vectored Foot-and-Mouth Disease (AdFMD) vaccines and include:

  • Manufacturing services for AdFMD experimental vaccines (monovalent or multivalent) from
  • AdFMD monovalent master seed derived viruses (3-4) and master cell bank.
  • Analytical testing services including, but not limited to vaccine quantification using established or new assays (e.g., TCID50, FIAD50, PFU, PU and/or ELISA) for AdFMD experimental vaccines.
  • Submission to USDA CVB of production and test report and supporting reports completed with material and materials.
  • Regulatory services associated with obtaining approvals to ship AdFMD experimental vaccines to
  • DHS S&T PIADC for BSL-3 biocontainment trials.
  • Export of AdFMD experimental vaccines to selected overseas country for use in field trials.

Further details are available via Solicitation Number: HSHQDC-15-I-CBFMD. The response deadline is March 6, 2015.

Tags: AdenovirusAgro-DefenseDHSFMDRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC